Patents by Inventor Olav Asmund Smidsrod

Olav Asmund Smidsrod has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligo-guluronate and galacturonate compositions
    Patent number: 8841279
    Abstract: The invention provides a pharmaceutical composition comprising a macromolecular drug and an oligoguluronate or oligogalacturonate, e.g., having a number average degree of polymerization in the range 5 to 18, a guluronate (or galacturonate) fraction (FG) of at least 0.80, a mannuronate fraction (FM) of no more than 0.20, and having at least 95% mole with a degree of polymerization less than 20. The composition may be used in a method of treatment which comprises administering the composition to a mucosal surface in a human or non-human vertebrate subject.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: September 23, 2014
    Assignee: Norwegian University of Science and Technology
    Inventors: Catherine Taylor, Kurt Ingar Draget, Olav Asmund Smidsrod
  • Use of oligouronates for treating mucus hyperviscosity
    Patent number: 8754063
    Abstract: A method of treatment of a human or non-human subject to combat mucosal hyperviscosity in the respiratory tract, which method includes application to a mucosal surface in the tract in the subject of an effective amount of a physiologically tolerable oligouronate. Related compositions containing physiologically tolerable oligouronates are also described.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: June 17, 2014
    Assignee: NTNU Technology Transfers AS
    Inventors: Catherine Taylor, Kurt Ingar Draget, Olav Asmund Smidsrod
  • Mucosal treatment
    Patent number: 8673878
    Abstract: The invention provides a method of treatment of a female human or non-human subject to enhance cervical mucus penetrability by spermatozoa, which method comprises vaginally applying to said subject an effective amount of a spermicide-free, physiologically tolerable oligouronate.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: March 18, 2014
    Assignee: NTNU Technology Transfer AS
    Inventors: Catherine Taylor, Kurt Ingar Draget, Olav Asmund Smidsrod
  • OLIGO-GULURONATE AND GALACTURONATE COMPOSITIONS
    Publication number: 20100152122
    Abstract: The invention provides a pharmaceutical composition comprising a macromolecular drug and an oligoguluronate or oligogalacturonate, e.g., having a number average degree of polymerization in the range 5 to 18, a guluronate (or galacturonate) fraction (FG) of at least 0.80, a mannuronate fraction (FM) of no more than 0.20, and having at least 95% mole with a degree of polymerization less than 20. The composition may be used in a method of treatment which comprises administering the composition to a mucosal surface in a human or non-human vertebrate subject.
    Type: Application
    Filed: April 11, 2008
    Publication date: June 17, 2010
    Applicant: NTNU TECHNOLOGY TRANSFER AS
    Inventors: Catherine Taylor, Kurt Ingar Drager, Olav Asmund Smidsrod
  • MUCOSAL TREATMENT
    Publication number: 20090156549
    Abstract: The invention provides a method of treatment of a female human or non-human subject to enhance cervical mucus penetrability by spermatozoa, which method comprises vaginally applying to said subject an effective amount of a spermicide-free, physiologically tolerable oligouronate.
    Type: Application
    Filed: October 6, 2006
    Publication date: June 18, 2009
    Applicant: NTNU TECHNOLOGY TRANSFER AS
    Inventors: Catherine Taylor, Kurt Ingar Draget, Olav Asmund Smidsrod
  • Use of Oligouronates for Treating Mucus Hyperviscosity
    Publication number: 20090010914
    Abstract: The invention provides a method of treatment of a human or non-human subject to combat mucosal hyperviscosity in the respiratory tract, which method comprises application to a mucosal surface in said tract in said subject of an effective amount of a physiologically tolerable oligouronate.
    Type: Application
    Filed: October 6, 2006
    Publication date: January 8, 2009
    Applicant: NTNU tECHNOLOGY tRANSFER AS
    Inventors: Catherine Taylor, Kurt Ingar Draget, Olav Asmund Smidsrod